These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 3292151

  • 21. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW, Haley NR, Adamson JW.
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract] [Full Text] [Related]

  • 22. The end stage renal disease program.
    Goodkin DA.
    N Engl J Med; 1993 Jul 08; 329(2):140; author reply 140-1. PubMed ID: 8510703
    [No Abstract] [Full Text] [Related]

  • 23. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M, Abad Gosálvez A, Colomina Avilés J, Pascual Pérez R, Ferriz Moreno P.
    An Med Interna; 1995 Apr 08; 12(4):187-8. PubMed ID: 7620064
    [Abstract] [Full Text] [Related]

  • 24. Erythropoietin.
    Beresford CH.
    N Z Med J; 1989 Apr 26; 102(866):185-6. PubMed ID: 2652007
    [No Abstract] [Full Text] [Related]

  • 25. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep 22; 31(801):85-6. PubMed ID: 2671624
    [No Abstract] [Full Text] [Related]

  • 26. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW, Johnson CA.
    Am J Kidney Dis; 1991 Oct 22; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia.
    Böcker A, Reimers E, Nonnast-Daniel B, Kühn K, Koch KM, Scigalla P, Braumann KM, Brunkhorst R, Böning D.
    Contrib Nephrol; 1988 Oct 22; 66():165-75. PubMed ID: 3391031
    [No Abstract] [Full Text] [Related]

  • 35. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A, Takaku F, Mizoguchi H, Kubo K, Ota K, Shimizu N, Tanaka K, Mimura N, Nihei H, Koshikawa S.
    Int J Cell Cloning; 1988 May 22; 6(3):179-91. PubMed ID: 3397592
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Growth inhibition of erythroid colonies by autologous sera and the clinical effect of erythropoietin in chronic renal disease].
    Wang JY, Hotta T, Murate T, Inoue C, Saito H, Ikeda Y, Ogawa H, Saito A.
    Rinsho Ketsueki; 1989 Jul 22; 30(7):975-9. PubMed ID: 2810799
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.